You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 5, February 7, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Opportunities for Specific Diseases and Disorders
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •HIV/AIDS
 •Tuberculosis/ Other Mycobacterium
 •Immunization
 •Statistics and Research Methods
 •Malaria
 •Immunology
 •Immunologic Disorders
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prospects for Vaccines to Protect Against AIDS, Tuberculosis, and Malaria

Norman L. Letvin, MD; Barry R. Bloom, PhD; Stephen L. Hoffman, MD

JAMA. 2001;285:606-611.

Given the scope of the worldwide health problems caused by the acquired immunodeficiency syndrome, tuberculosis, and malaria, it is imperative that vaccines be developed to prevent these infections. Recent advances in the understanding of these diseases suggest that T-lymphocyte–mediated immunity is important in containing these infections. The application of novel vaccine technologies for eliciting this type of immunity promises to provide successful vaccines for controlling the spread of these deadly infections.


Author Affiliations: Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass (Dr Letvin); Office of the Dean, Harvard School of Public Health, Boston, Mass (Dr Bloom); and Malaria Department, Naval Medical Research Center, Silver Spring, Md (Dr Hoffman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Global Transcriptional Profile of Mycobacterium tuberculosis during THP-1 Human Macrophage Infection
Fontan et al.
Infect. Immun. 2008;76:717-725.
ABSTRACT | FULL TEXT  

A Booster for Tuberculosis Vaccines
Dye
JAMA 2004;291:2127-2128.
FULL TEXT  

Latent tuberculosis: revised treatment guidelines
Weir and Fisman
CMAJ 2003;169:937-938.
FULL TEXT  

Identification of a Promiscuous T-Cell Epitope in Mycobacterium tuberculosis Mce Proteins
Panigada et al.
Infect. Immun. 2002;70:79-85.
ABSTRACT | FULL TEXT  

Paediatric HIV infection: correlates of protective immunity and global perspectives in prevention and management
Goulder et al.
Br Med Bull 2001;58:89-108.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.